Associate Professor of Medicine Dana-Farber Cancer Institute Brookline, Massachusetts, United States
Description: This session will delve into the complexities of optimizing molecular testing and reporting, with a focus on balancing the expectations of oncologists and the practical realities faced by laboratories. Attendees will gain a better understanding of how to meet the evolving needs of oncologists while ensuring molecular testing is accurate, efficient, and feasible within the laboratory setting.
Learning Objectives: - Explore strategies for meeting oncologist demands for timely results while managing the logistical constraints of laboratory workflows. - Evaluate pros and cons of panel size, weighing larger comprehensive panels against smaller efficient targeted panels. - Explain clinical utility of reporting lower VAFs while enumerating technical considerations for optimizing limit of detection. - Describe best practices for integrated reporting of molecular, genetic, and histologic findings with consideration for real-life challenges with reporting systems
